Clinical features of ocular damage in systemic lupus erythematosus and risk factors of hydroxychloroquine related complications

T Cheng, X Gu, Z Yang, C Wang, Y Chen… - Survey of …, 2024 - Elsevier
Ocular damage in systemic lupus erythematosus (SLE) may cause insidious visual
impairment, but its clinical features and the risk of hydroxychloroquine (HCQ)-related …

The role of gut microbiota in different murine models of systemic lupus erythematosus

R Lu, XM Luo - Autoimmunity, 2024 - Taylor & Francis
Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by immune
system dysfunction that can lead to serious health issues and mortality. Recent …

Plasma proteomics reveals an improved cardio-metabolic profile in patients with type 2 diabetes post-liraglutide treatment

AA Ekhzaimy, A Masood… - Diabetes and …, 2022 - journals.sagepub.com
Background Diabetes mellitus is a chronic multisystem disease with a high global
prevalence, including in Saudi Arabia. The Glucagon-like Peptide (GLP-1) receptor agonist …

Effects of hydroxychloroquine on the human placenta—findings from in vitro experimental data and a systematic review

RE Scott, SL Greenwood, DJL Hayes, BC Baker… - Reproductive …, 2019 - Elsevier
Hydroxychloroquine (HCQ), a toll like receptor (TLR) 7 and 9 antagonist, is used during
pregnancy for inflammatory conditions with limited understanding of its placental toxicology …

[HTML][HTML] Enrichment of complement, immunoglobulins, and autoantibody targets in the proteome of platelets from patients with systemic lupus erythematosus

CP Linge, A Jern, H Tydén, B Gullstrand… - Thrombosis and …, 2022 - thieme-connect.com
Background Systemic lupus erythematosus (SLE) is a complex disease characterized by
autoimmunity toward apoptotic cells, excessive amounts of circulating immune complexes …

Anti-phospholipid syndrome: Current opinion on mechanisms involved, laboratory characterization and diagnostic aspects

J Amiral, M Peyrafitte, C Dunois, AM Vissac… - … and Apheresis Science, 2017 - Elsevier
Anti-phospholipid syndrome is a complex and severe clinical situation, associated with
symptoms such as recurrent thrombosis, arterial or venous, at any site, pregnancy loss, and …

Importance of Efferocytosis in COVID-19 Mortality

A Erol - Infection and Drug Resistance, 2022 - Taylor & Francis
COVID-19 is a generally benign coronavirus disease that can spread rapidly, except for
those with a group of risk factors. Since the pathogenesis responsible for the severity of the …

[HTML][HTML] Distinct and overlapping effects of β2-glycoprotein I conformational variants in ligand interactions and functional assays

G Szabó, K Pénzes, B Torner, M Fagyas, T Tarr… - Journal of …, 2020 - Elsevier
One of the most abundant coagulation proteins is β 2-glycoprotein I (β 2 GPI) that is present
in humans at a concentration of around 200 mg/L. Its physiological role is only partially …

In silico identification of new inhibitors for βeta-2-glycoprotein I as a major antigen in antiphospholipid antibody syndrome

S Mahdian, M Zarrabi, A Moini, M Movahedi… - Journal of Molecular …, 2020 - Springer
Beta 2 glycoprotein I (β2GPI) is a major antigen for autoantibodies present in
antiphospholipid antibody syndrome (APS). β2GPI is a single polypeptide with five repeated …

Impact of autoantibody-mediated procoagulant platelets and thrombus formation in antiphospholipid syndrome

C Schnaidt, J Zlamal, T Bakchoul - Hämostaseologie, 2024 - thieme-connect.com
Method For the investigation of anti-β 2 GPI AAb-mediated PLT alterations, a flow cytometry
(FC)-based protocol was employed. To study the impact of anti-β 2 GPI AAb-mediated PLT …